![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » OXFORD BIOMEDICA IS GRANTED KEY PATENTS IN CHINA
OXFORD BIOMEDICA IS GRANTED KEY PATENTS IN CHINA
July 11, 2005
These are the first patents covering the commercial use of the Company's LentiVector technology in China, the only country in the world with an approved gene therapy product and a country where opportunities for innovative pharmaceutical development is widely predicted to grow substantially over the next decade.
Medical News Today (http://www.medicalnewstoday.com/medicalnews.php?newsid=27218&nfid=mnf)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct